Fractional Exhaled Nitric Oxide (FeNO) in Patients with Stable Chronic Obstructive Pulmonary Disease: Short-Term Variability and Potential Clinical Implications
2022; Multidisciplinary Digital Publishing Institute; Volume: 12; Issue: 11 Linguagem: Inglês
10.3390/jpm12111906
ISSN2075-4426
AutoresPasquale Ambrosino, Salvatore Fuschillo, Mariasofia Accardo, Marco Mosella, Antonio Molino, Giorgio Alfredo Spedicato, Andréa Motta, Mauro Maniscalco,
Tópico(s)Respiratory Support and Mechanisms
ResumoThe use of fractional exhaled nitric oxide (FeNO) has been proposed for identifying and monitoring eosinophilic airway inflammation in chronic obstructive pulmonary disease (COPD). To explore the clinical utility of FeNO in COPD, we aimed to assess its short-term variability in a clinically stable COPD cohort.
Referência(s)